Keywords: biovitrum, enters, nordic, benefix, co-promo, deal, stockholm

Biovitrum enters Nordic BeneFIX co-promo deal

Article | 13 August 2007

Print This

Stockholm, Sweden-based Biovitrum has entered into a new agreement with US drug major Wyeth to co-promote BeneFIX, coagulation factor IX ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in